Therapeutic options of TCM for organ injuries associated with COVID-19 and the underlying mechanism
- PMID: 32798019
- PMCID: PMC7405862
- DOI: 10.1016/j.phymed.2020.153297
Therapeutic options of TCM for organ injuries associated with COVID-19 and the underlying mechanism
Abstract
Background: Coronavirus disease-2019 (COVID-19) caused by infection with severe acute respiratory coronavirus-2 (SARS-CoV-2) has been spreading rapidly throughout China and in other countries since the end of 2019. The World Health Organization (WHO) has declared that the epidemic is a public health emergency of international concerns. The timely and appropriate measures for treating COVID-19 in China, which are inseparable from the contribution of traditional Chinese medicine (TCM), have won much praise of the world.
Purpose: This review aimed to summarize and discuss the essential role of TCM in protecting tissues from injuries associated with COVID-19, and accordingly to clarify the possible action mechanisms of TCM from the perspectives of anti-inflammatory, antioxidant and anti-apoptotic effects.
Methods: Electronic databases such as Pubmed, ResearchGate, Science Direct, Web of Science, medRixv and Wiley were used to search scientific literatures.
Results: The present review found that traditional Chinese herbs commonly used for the clinical treatment of organ damages caused by COVID-19, such as Scutellaria baicalensis, Salvia miltiorrhizaSalvia miltiorrhiza, and ginseng, could act on multiple signaling pathways involved in inflammation, oxidative stress and apoptosis.
Conclusion: TCM could protect COVID-19 patients from tissue injuries, a protection that might be, at least partially, attributed to the anti-inflammatory, antioxidant and anti-apoptotic effects of the TCM under investigation. This review provides evidence and support for clinical treatment and novel drug research using TCM.
Keywords: Active component; Coronavirus disease 2019; Pharmacological mechanism; Severe acute respiratory coronavirus-2; Signaling pathway; Traditional Chinese medicine.
Copyright © 2020 Elsevier GmbH. All rights reserved.
Conflict of interest statement
None.
Figures
References
-
- Cai Y., Yu S.L., Zhang R.H. The effect of lycium barbarum polysaccharideson protecting brain function of lead-exposed mice. JEOM. 2005;22:533–534.
-
- Cao A.L., Wang L., Chen X., Wang Y.M., Guo H.J., Chu S., Liu C., Zhang X.M., Peng W. Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy. Lab. Invest. 2016;96:610–622. - PubMed
-
- Cao M., Zhang D., Wang Y., Lu Y., Zhu X., Li Y., Xue H., Lin Y., Zhang M., Sun Y., Yang Z., Shi J., Wang Y., Zhou C., Dong Y., Peng L., Liu P., Dudek S.M., Xiao Z., Lu H., Peng L. Clinical features of patients infected with the 2019 novel coronavirus (COVID-19) in Shanghai, China. medRxiv. 2020 doi: 10.1101/2020.03.04.20030395. - DOI
-
- Chen H.I., Ou H.C., Chen C.Y., Yu S.H., Cheng S.M., Wu X.B., Lee S.D. Neuroprotective effect of Rhodiola crenulata in D-galactose-induced aging model. Am. J. Chin. Med. 2020;48:245–258. - PubMed
-
- Chen L., Ge G., Rong Y., Fu W., Zheng M., Zhao Y., Yuan W., Luan X., Zhang L., Zhang H., Chen H. Application and research progress of traditional Chinese medicine in prevention and treatment of coronavirus disease 2019. Acta Univ. Tradict. Med. Sin. Pharmacol. Shanghai. 2020;34:1–8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
